Effects of aging on serotonin transporter availability and its response to fluvoxamine in the living brain: PET study with [11C](+)McN5652 and [11C] (‐)McN5652 in conscious monkeys
- 9 April 2001
- Vol. 40 (3) , 170-179
- https://doi.org/10.1002/syn.1039
Abstract
Age‐related changes in the serotonin transporter (SERT) in the living brains of conscious young (5.9 ± 1.8 years old) and aged (19.0 ± 3.3 years old) monkeys (Macaca mulatta) were evaluated in combination with [11C](+)McN5652 and its inactive enantiomer [11C](‐)McN5652 by high‐resolution positron emission tomography (PET). For the quantitative analysis of SERT binding in vivo, two serial PET scans with [11C](+)McN5652 and [11C](‐)McN5652 were performed in the same animals in a day and the differences in radioactivities of [11C](+)McN5652 vs. [11C](‐)McN5652 measured from 41–91 min postinjection were calculated as an estimate of specific ligand binding. Higher specific binding of SERT was observed in the thalamus and striatum, regions known to contain high densities of SERT by in vitro assay, with intermediate levels in the pons, hippocampus, cingulate gyrus, and cortical regions and lower levels in the cerebellum in both young and aged monkeys. Almost all regions assayed except the cerebellum showed significant age‐related decreases in the specific binding of SERT, which showed reverse correlation with cortisol level in plasma. When the SERT blocker fluvoxamine (1 mg/kg) was administered intravenously 30 min after tracer injection, specific binding of SERT was displaced in both age groups. However, the degree of displacement was more marked in young than in aged monkeys. Cortisol level in plasma was significantly higher in aged than in young animals. These observations demonstrate the usefulness of the combined use of [11C](+)McN5652 and [11C](‐)McN5652 as an indicator for the age‐related changes in cortical SERT measured noninvasively by PET. In addition, these observations suggest that the age‐related impairment of SERT sensitivity for fluvoxamine might be related to the reduced efficacy of antidepressant therapy in elderly patients with depression. Synapse 40:170–179, 2001.Keywords
This publication has 43 references indexed in Scilit:
- Evaluation of PET ligands (+)N‐[11C]ethyl‐3‐piperidyl benzilate and (+)N‐[11C]propyl‐3‐piperidyl benzilate for muscarinic cholinergic receptors: A PET study with microdialysis in comparison with (+)N‐[11C]methyl‐3‐piperidyl benzilate in the conscious monkey brainSynapse, 2001
- Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: A PET study in comparison with [11C]4-MPBSynapse, 2000
- Ketamine decreased striatal [11C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysisSynapse, 2000
- [11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with petLife Sciences, 1993
- Aging and 3H-paroxetine binding in rat brain: Effect of imipramine and tetrahydroacridineLife Sciences, 1993
- Synthesis of a radiotracer for studying serotonin uptake sites with positron emission tomography: [11C]McN‐5652‐ZJournal of Labelled Compounds and Radiopharmaceuticals, 1992
- Radiosynthesis and evaluation of N-(3-[18F]fluoropropyl)paroxetine as a radiotracer for in vivo labeling of serotonin uptake sites by PETInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
- Regional distribution of serotonergic pre‐ and postsynaptic markers in human brainActa Psychiatrica Scandinavica, 1989
- Synthesis of a radiotracer for studying serotonin uptake sites: Carbon‐11 labeled N‐methylparoxetineJournal of Labelled Compounds and Radiopharmaceuticals, 1989
- Corticosterone receptors decline in a site-specific manner in the aged rat brainBrain Research, 1983